Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease
- 29 October 2004
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 1025 (1-2), 98-105
- https://doi.org/10.1016/j.brainres.2004.08.004
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Synthesis and Evaluation of Two 18F-Labeled 6-Iodo-2-(4‘-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine Derivatives as Prospective Radioligands for β-Amyloid in Alzheimer's DiseaseJournal of Medicinal Chemistry, 2004
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- The Binding of 2-(4′-Methylaminophenyl)Benzothiazole to Postmortem Brain Homogenates Is Dominated by the Amyloid ComponentJournal of Neuroscience, 2003
- In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer’s brain using the positron emission tomography molecular imaging probe 2-(1-{6-[(2-[18F]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrileNeuroscience, 2003
- IMPY: an improved thioflavin-T derivative for in vivo labeling of β-amyloid plaquesBrain Research, 2002
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for β-Amyloid Plaques in Alzheimer's DiseaseJournal of Neuroscience, 2001
- Novel Stilbenes as Probes for Amyloid PlaquesJournal of the American Chemical Society, 2001
- Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brainJournal of Neurochemistry, 2001
- IPT: A novel iodinated ligand for the CNS dopamine transporterSynapse, 1995